Across TCGA pan-cancer cohorts, FKBP14-AS1 RNA is linked to patient survival in 23 of 34 cancer types, making it the most broadly survival-associated FKBP14-AS1 data layer.

The strongest signal is observed in cholangiocarcinoma (CHOL), where higher FKBP14-AS1 RNA is associated with better overall survival. In most high-consensus cancer types, elevated FKBP14-AS1 expression acts as an unfavorable survival marker, although some lineages such as CHOL and UCS show a favorable association.

CHOL, LGG, and KIRP are the cancer types where FKBP14-AS1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
CHOL	OS	Median	All	0.763	0.352	.002	55	view →
LGG	DFS	Median	All	0.644	0.835	<.001	54	view →
KIRP	OS	Median	III,IV	0.256	0.670	.001	33	view →
LUSC	DFS	Median	III,IV	0.406	0.912	.004	24	view →
KIRC	DFS	Quartile	All	0.588	0.785	.010	24	view →
UCEC	DFS	Median	All	0.866	0.926	.009	22	view →
ACC	DFS	Quartile	All	0.484	0.796	.003	20	view →
BLCA	DFS	Tertile	All	0.447	0.667	.014	19	view →
UCS	DFS	Tertile	IV	0.981	0.484	.024	18	view →
MESO	DFS	Quartile	All	0.229	0.448	.009	15	view →
ESCA	OS	Quartile	All	0.537	0.753	.012	10	view →
SKCM	DFS	Median	All	0.689	0.822	.028	8	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 23 lineages.

Exploration

Same gene, other analysis: FKBP14-AS1 tumor-vs-normal RNA expression · all FKBP14-AS1 data types